Higuero T, Abramowitz L, Castinel A, Fathallah N, Hemery P, Laclotte Duhoux C, Pigot F, Pillant-Le Moult H, Senjoux A, Siproudhis L, Staumont G, Suduca JM, Vinson-Bonnet B
2. Oncology (Tumor Inhibition)
IGF-1 LR3 retains the pharmacological activity of IGF-1 as an agonist of the IGF-1 receptor while possessing significantly improved metabolic stability
Li 2024), pulmonary fibrosis models (Han 2022
Difficulty walking
Anyone experiencing hair loss should consult a GP for accurate diagnosis before using unregulated products, as an underlying cause may require specific treatment